Unlike hexarelin or GHRP-6, ipamorelin does not provoke meaningful increases in cortisol, prolactin, or ACTH at standard doses [1]

E N D Presentation Transcript GLP-1 Agonists and Cardiovascular Health Alan Mathis PharmD Candidate 2013 www.DIABETESINCONTROL.COM Part 2 of 2 Change in Triglycerides and HDL-C as Function of Weight-Change Quartile at 82 Weeks Effects of GLP-1 agonists on inflammatory markers GLP-1 agonists have been shown to reduce several inflammatory markers including plasminogen activator inhibitor-1 (PAI-1), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) E-selectin was not significantly reduced C-reactive protein has also been associated with increased cardiovascular disease Patients treated with exenatide showed marked decrease in c-reactive protein levels after an 82-week study (from 3.21mg/dL to 1.35 mg/dL) Kendall DM, Bhole D, Guan X, et al.: Exenatide treatment for 82 weeks reduced C-reactive protein, HbAlc, and body weight in patients with type 2 diabetes mellitus

Trulicity Pronunciation: TRU-li-si-tee Generic name: dulaglutide Other brand names of dulaglutide include: Trulicity pen Dosage form: single-use pen injection for subcutaneous use (0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, 4.5 mg/0.5 mL) Drug class: GLP-1 Drugs What is Trulicity
Complete prevention is not guaranteed, but PlexusDx-compounded semaglutide injections (at $189/mo month-to-month, or from $149/mo on the 6-month plan) allow personalized dose and escalation timing to minimize symptom severity